BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Q, Yang F, Miao Q, Krawitt EL, Gershwin ME, Ma X. The clinical phenotypes of autoimmune hepatitis: A comprehensive review. J Autoimmun. 2016;66:98-107. [PMID: 26614611 DOI: 10.1016/j.jaut.2015.10.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Lou J, Jiang Y, Rao B, Li A, Ding S, Yan H, Zhou H, Liu Z, Shi Q, Cui G, Yu Z, Ren Z. Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals. Front Cell Infect Microbiol 2020;10:342. [PMID: 32850468 DOI: 10.3389/fcimb.2020.00342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Thompson RA, Isin EM, Ogese MO, Mettetal JT, Williams DP. Reactive Metabolites: Current and Emerging Risk and Hazard Assessments. Chem Res Toxicol 2016;29:505-33. [DOI: 10.1021/acs.chemrestox.5b00410] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 13.2] [Reference Citation Analysis]
3 Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis. J Clin Exp Hepatol 2020;10:339-76. [PMID: 32655238 DOI: 10.1016/j.jceh.2020.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
4 Lian M, Li B, Xiao X, Yang Y, Jiang P, Yan L, Sun C, Zhang J, Wei Y, Li Y, Chen W, Jiang X, Miao Q, Chen X, Qiu D, Sheng L, Hua J, Tang R, Wang Q, Eric Gershwin M, Ma X. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone. Autoimmun Rev. 2017;16:875-882. [PMID: 28564616 DOI: 10.1016/j.autrev.2017.05.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
5 Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, Wang FS, Wei L, Wang Q, Sun Y, Hong Y, Rao H, Efe C, Lau G, Payawal D, Gani R, Lindor K, Jafri W, Omata M, Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int 2021;15:223-57. [PMID: 33942203 DOI: 10.1007/s12072-021-10170-1] [Reference Citation Analysis]
6 Wang Z, Sheng L, Yang Y, Yang F, Xiao X, Hua J, Guo C, Wei Y, Tang R, Miao Q, Zhang J, Li Y, Fang J, Qiu D, Krawitt EL, Bowlus CL, Gershwin ME, Wang Q, Ma X. The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive Review. Clinic Rev Allerg Immunol 2017;52:424-35. [DOI: 10.1007/s12016-016-8583-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
7 Enomoto H, Nishiguchi S. Similarities and Differences in Autoimmune Hepatitis Epidemiology between East and West: Autoimmune Hepatitis in East Asia, Southeast Asia, and South Asia. Inflamm Intest Dis 2017;1:150-8. [PMID: 29922671 DOI: 10.1159/000454879] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
8 Oka S, Higuchi T, Furukawa H, Nakamura M, Komori A, Abiru S, Nagaoka S, Hashimoto S, Naganuma A, Naeshiro N, Yoshizawa K, Shimada M, Nishimura H, Tomizawa M, Kikuchi M, Makita F, Yamashita H, Ario K, Yatsuhashi H, Tohma S, Kawasaki A, Tsuchiya N, Migita K. Association of a single nucleotide polymorphism in TNIP1 with type-1 autoimmune hepatitis in the Japanese population. J Hum Genet 2018;63:739-44. [PMID: 29559739 DOI: 10.1038/s10038-018-0440-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Wendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Nevens F, Samuel D, Simpson KJ, Yaron I, Bernardi M. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. Journal of Hepatology 2017;66:1047-81. [DOI: 10.1016/j.jhep.2016.12.003] [Cited by in Crossref: 280] [Cited by in F6Publishing: 221] [Article Influence: 56.0] [Reference Citation Analysis]
10 Tanaka A, Kono H, Leung PSC, Gershwin ME. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus. Cell Immunol 2020;347:104021. [PMID: 31767117 DOI: 10.1016/j.cellimm.2019.104021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Singh K, Maung P, Vadivelu K. Ranitidine-Associated Autoimmune Hepatitis. Am J Ther 2018;25:e758-60. [PMID: 29672333 DOI: 10.1097/MJT.0000000000000767] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Buechter M, Manka P, Heinemann FM, Lindemann M, Baba HA, Schlattjan M, Canbay A, Gerken G, Kahraman A. Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients. World J Gastroenterol 2018; 24(13): 1410-1418 [PMID: 29632422 DOI: 10.3748/wjg.v24.i13.1410] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
13 Selmi C, Generali E, Gershwin ME. Rheumatic Manifestations in Autoimmune Liver Disease. Rheumatic Disease Clinics of North America 2018;44:65-87. [DOI: 10.1016/j.rdc.2017.09.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
14 Mieli-vergani G, Vergani D, Baumann U, Czubkowski P, Debray D, Dezsofi A, Fischler B, Gupte G, Hierro L, Indolfi G, Jahnel J, Smets F, Verkade HJ, Hadžić N. Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement. Journal of Pediatric Gastroenterology & Nutrition 2018;66:345-60. [DOI: 10.1097/mpg.0000000000001801] [Cited by in Crossref: 100] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
15 Tanaka A, Leung PSC, Young HA, Gershwin ME. Therapeutic and immunological interventions in primary biliary cholangitis: from mouse models to humans. Arch Med Sci 2018;14:930-40. [PMID: 30002712 DOI: 10.5114/aoms.2017.70995] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Wang QX, Yan L, Ma X. Autoimmune Hepatitis in the Asia-Pacific Area. J Clin Transl Hepatol 2018;6:48-56. [PMID: 29577032 DOI: 10.14218/JCTH.2017.00032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Takai S, Inoue J, Kogure T, Kakazu E, Ninomiya M, Iwata T, Umetsu T, Nakamura T, Sano A, Shimosegawa T. Acute-onset Autoimmune Hepatitis in a Young Woman with Type 1 Diabetes Mellitus. Intern Med 2018;57:1591-6. [PMID: 29321432 DOI: 10.2169/internalmedicine.9728-17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Floreani A, Tanaka A, Bowlus C, Gershwin ME. Geoepidemiology and changing mortality in primary biliary cholangitis. J Gastroenterol 2017;52:655-62. [DOI: 10.1007/s00535-017-1333-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
19 Liu T, Xia Y, Li J, Li S, Feng J, Wu L, Zhang R, Xu S, Cheng K, Zhou Y, Zhou S, Dai W, Chen K, Wang F, Lu J, Zhou Y, Guo C. Shikonin Attenuates Concanavalin A-Induced Acute Liver Injury in Mice via Inhibition of the JNK Pathway. Mediators Inflamm. 2016;2016:2748367. [PMID: 27293314 DOI: 10.1155/2016/2748367] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
20 Lian M, Selmi C, Gershwin ME, Ma X. Myeloid Cells and Chronic Liver Disease: a Comprehensive Review. Clin Rev Allergy Immunol. 2018;54:307-317. [PMID: 29313221 DOI: 10.1007/s12016-017-8664-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Gil-farina I, Di Scala M, Salido E, López-franco E, Rodríguez-garcía E, Blasi M, Merino J, Aldabe R, Prieto J, Gonzalez-aseguinolaza G. Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis. J I 2016;197:2145-56. [DOI: 10.4049/jimmunol.1600228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
22 Liberal R, Krawitt EL, Vierling JM, Manns MP, Mieli-Vergani G, Vergani D. Cutting edge issues in autoimmune hepatitis. J Autoimmun. 2016;75:6-19. [PMID: 27502148 DOI: 10.1016/j.jaut.2016.07.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 9.7] [Reference Citation Analysis]
23 Bozzini AB, Neder L, Silva CA, Porta G. Decreased health-related quality of life in children and adolescents with autoimmune hepatitis. Jornal de Pediatria 2019;95:87-93. [DOI: 10.1016/j.jped.2017.10.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
24 Chen RL, Wang QX, Ma X. Precision medicine for autoimmune hepatitis. J Dig Dis 2019;20:331-7. [PMID: 31099976 DOI: 10.1111/1751-2980.12786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Chaouali M, Kochkar R, Messadi A, Tezeghdenti A, Azaiez MB, Abdallah HB, Yacoubi-oueslati B, Ghazouani E. Distribution of HLA-DRB1/DQB1 alleles and DRB1-DQB1 haplotypes among Tunisian patients with autoimmune hepatitis. Egyptian Journal of Medical Human Genetics 2017;18:335-9. [DOI: 10.1016/j.ejmhg.2017.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
26 Jin L, Fu X, Yao S, Yang J, Ning G, Zhang Z. Protective effects of protopanaxatriol on acute liver injury induced by concanavalin A. Naunyn Schmiedebergs Arch Pharmacol 2019;392:81-7. [PMID: 30269219 DOI: 10.1007/s00210-018-1567-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
27 Qu L, Wang S, Yang K, Brigstock DR, Sun L, Gao R. CD4 + Foxp3 + CD25 +/− Tregs characterize liver tissue specimens of patients suffering from drug-induced autoimmune hepatitis: A clinical-pathological study. Hepatobiliary & Pancreatic Diseases International 2018;17:133-9. [DOI: 10.1016/j.hbpd.2018.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Serrya MS, Zaghloul MS. Mycophenolate mofetil attenuates concanavalin A-induced acute liver injury through modulation of TLR4/NF-κB and Nrf2/HO-1 pathways. Pharmacol Rep 2020;72:945-55. [PMID: 32048261 DOI: 10.1007/s43440-019-00055-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Chaiteerakij R, Sanpawat A, Avihingsanon A, Treeprasertsuk S. Autoimmune hepatitis in human immunodeficiency virus-infected patients: A case series and review of the literature. World J Gastroenterol 2019; 25(35): 5388-5402 [PMID: 31558881 DOI: 10.3748/wjg.v25.i35.5388] [Cited by in CrossRef: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Iyer MH, Kumar JE, Kumar N, Gorelik L, Hussain N, Stein E, Bhatt AM, Bhandary S, Essandoh MK, Flores AS. Transfusion-Related Acute Lung Injury During Liver Transplantation: A Scoping Review. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00359-1. [PMID: 34099375 DOI: 10.1053/j.jvca.2021.04.033] [Reference Citation Analysis]
31 Renand A, Habes S, Mosnier JF, Aublé H, Judor JP, Vince N, Hulin P, Nedellec S, Métairie S, Archambeaud I, Brouard S, Gournay J, Conchon S. Immune Alterations in Patients With Type 1 Autoimmune Hepatitis Persist Upon Standard Immunosuppressive Treatment. Hepatol Commun 2018;2:968-81. [PMID: 30094407 DOI: 10.1002/hep4.1202] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
32 Wu S, Yang Z, Zhou J, Zeng N, He Z, Zhan S, Jia J, You H. Systematic review: diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitis. Hepatol Int 2019;13:91-101. [PMID: 30443702 DOI: 10.1007/s12072-018-9907-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
33 Chaouali M, Azaiez MB, Tezeghdenti A, Lagha A, Yacoubi-Oueslati B, Ghazouani E, Abdallah HB, Kochkar R. Association of TNF-α-308 Polymorphism with Susceptibility to Autoimmune Hepatitis in Tunisians. Biochem Genet 2018;56:650-62. [PMID: 29845365 DOI: 10.1007/s10528-018-9867-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Higuchi T, Oka S, Furukawa H, Nakamura M, Komori A, Abiru S, Hashimoto S, Shimada M, Yoshizawa K, Kouno H, Naganuma A, Ario K, Kaneyoshi T, Yamashita H, Takahashi H, Makita F, Yatsuhashi H, Ohira H, Migita K. Role of deleterious single nucleotide variants in the coding regions of TNFAIP3 for Japanese autoimmune hepatitis with cirrhosis. Sci Rep 2019;9:7925. [PMID: 31138864 DOI: 10.1038/s41598-019-44524-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
35 Higuchi T, Oka S, Furukawa H, Tohma S, Yatsuhashi H, Migita K. Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response. Hum Genomics 2021;15:6. [PMID: 33509297 DOI: 10.1186/s40246-020-00301-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Wang M, Yin H, Xia Y, Tu Y, Zou X, Song W, Luo L, Wu H, Yang Y, Zan J, Liu Y, Dan H, Yin Q, You P. Huganbuzure Granule Attenuates Concanavalin-A-Induced Immune Liver Injury in Mice via Regulating the Balance of Th1/Th2/Th17/Treg Cells and Inhibiting Apoptosis. Evid Based Complement Alternat Med 2021;2021:5578021. [PMID: 34539800 DOI: 10.1155/2021/5578021] [Reference Citation Analysis]
37 Hao LR, Li XF, Gao C, Cao L, Han ZY, Gao H. Th17/Treg cell level and clinical characteristics of peripheral blood of patients with Sjogren's syndrome complicated with primary biliary cirrhosis. Medicine (Baltimore) 2019;98:e15952. [PMID: 31192933 DOI: 10.1097/MD.0000000000015952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Chi G, Feng XX, Ru YX, Xiong T, Gao Y, Wang H, Luo ZL, Mo R, Guo F, He YP, Zhang GM, Tian DA, Feng ZH. TLR2/4 ligand-amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6/IL-12/IL-4/IL-25 expression. Mol Immunol. 2018;99:171-181. [PMID: 29793131 DOI: 10.1016/j.molimm.2018.05.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
39 Malik N, Venkatesh SK. Imaging of autoimmune hepatitis and overlap syndromes. Abdom Radiol (NY). 2017;42:19-27. [PMID: 27999888 DOI: 10.1007/s00261-016-1019-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
40 Mubder M, Azab M, Jayaraj M, Cross C, Lankarani D, Dhindsa B, Pan JJ, Ohning G. Autoimmune hepatitis in patients with human immunodeficiency virus infection: A systematic review of the published literature. Medicine (Baltimore) 2019;98:e17094. [PMID: 31517833 DOI: 10.1097/MD.0000000000017094] [Reference Citation Analysis]
41 Chaouali M, Carvalho A, Tezeghdenti A, Ben Azaiez M, Cunha C, Ghazouani E, Kochkar R. Cytotoxic T lymphocyte antigen-4 gene polymorphisms and susceptibility to type 1 autoimmune hepatitis in the Tunisian population. Genes Dis 2018;5:256-62. [PMID: 30320190 DOI: 10.1016/j.gendis.2017.12.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
42 Li Y, Gong L, Weng L, Pan X, Liu C, Li M. Interleukin-39 exacerbates concanavalin A-induced liver injury. Immunopharmacol Immunotoxicol 2021;43:94-9. [PMID: 33412981 DOI: 10.1080/08923973.2020.1869778] [Reference Citation Analysis]
43 Shi Y, Wang Q, Rong J, Ren J, Song X, Fan X, Shen M, Xia Y, Wang N, Liu Z, Hu Q, Ye T, Yu L. Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitis. Eur J Med Chem 2019;179:182-95. [PMID: 31254920 DOI: 10.1016/j.ejmech.2019.06.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
44 Rao B, Lou J, Lu H, Liang H, Li J, Zhou H, Fan Y, Zhang H, Sun Y, Zou Y, Wu Z, Jiang Y, Ren Z, Yu Z. Oral Microbiome Characteristics in Patients With Autoimmune Hepatitis. Front Cell Infect Microbiol 2021;11:656674. [PMID: 34094998 DOI: 10.3389/fcimb.2021.656674] [Reference Citation Analysis]
45 Zachou K, Arvaniti P, Azariadis K, Lygoura V, Gatselis NK, Lyberopoulou A, Koukoulis GK, Dalekos GN. Prompt initiation of high-dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis. Hepatol Res 2019;49:96-104. [PMID: 30248210 DOI: 10.1111/hepr.13252] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
46 Chaouali M, Fernandes V, Ghazouani E, Pereira L, Kochkar R. Association of STAT4, TGFβ1, SH2B3 and PTPN22 polymorphisms with autoimmune hepatitis. Exp Mol Pathol 2018;105:279-84. [PMID: 30291855 DOI: 10.1016/j.yexmp.2018.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
47 Ma X, Qiu K. Chinese consensus on the diagnosis and management of autoimmune hepatitis (2015): Chinese Society of Hepatology, Chinese Society of Gastroenterology & amp; Chinese Society of Infectious Diseases. J Dig Dis. 2017; Apr 27. [Epub ahead of print]. [PMID: 28449401 DOI: 10.1111/1751-2980.12479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
48 Floreani A, Restrepo-jiménez P, Secchi MF, De Martin S, Leung PS, Krawitt E, Bowlus CL, Gershwin ME, Anaya J. Etiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity 2018;95:133-43. [DOI: 10.1016/j.jaut.2018.10.020] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
49 Zhou Y, Wu H, Zhao M, Chang C, Lu Q. The Bach Family of Transcription Factors: A Comprehensive Review. Clinic Rev Allerg Immunol 2016;50:345-56. [DOI: 10.1007/s12016-016-8538-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
50 Wang Y, Wang YL, Zhu YP, Xu WL, Huang JL, Chai XZ, Li M, Qian F, Zhu CW. Type 3 progressive familial intrahepatic cholestasis combined with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome: A case report. Shijie Huaren Xiaohua Zazhi 2022; 30(1): 56-60 [DOI: 10.11569/wcjd.v30.i1.56] [Reference Citation Analysis]
51 Xu Q, Sheng L, Bao H, Chen X, Guo C, Li H, Ma X, Qiu D, Hua J. Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis. J Gastroenterol Hepatol. 2017;32:639-644. [PMID: 27505153 DOI: 10.1111/jgh.13508] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
52 Chi G, Pei JH, Ma QY, Ru YX, Feng ZH. Chemical induced inflammation of the liver breaks tolerance and results in autoimmune hepatitis in Balb/c mice. Immunol Lett 2020;218:44-50. [PMID: 31794800 DOI: 10.1016/j.imlet.2019.11.010] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]